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Cauliflower mosaic virus (CaMV) open reading frame (ORF) IV encodes a coat protein precursor (pre-CP) harboring an N-terminal
extension that is cleaved off by the CaMV-encoded protease. In transfected cells, pre-CP is present in the cytoplasm, while the processed
form (p44) of CP is targeted to the nucleus, suggesting that the N-terminal extension might be involved in keeping the pre-CP in the
cytoplasm for viral assembly. This study reports for the first time the intracellular localization of the N-terminal extension during CaMV
infection in Brassica rapa. Immunogold-labeling electron microscopy using polyclonal antibodies directed to the N-terminal extension of the
pre-CP revealed that this region is closely associated with viral particles present in small aggregates, which we called small bodies, adjacent
to the main inclusion bodies typical of CaMV infection. Based on these results, we propose a model for viral assembly of CaMV.
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Cauliflower mosaic virus (CaMV), the type member of
the Caulimoviridae (reviewed in Hohn and Fu¨tterer, 1997),
is a double-stranded (ds) DNA virus of 8 kb. CaMV coat
protein (CP) is expressed from viral open reading frame
(ORF) IV as a precursor (pre-CP) harboring an N-terminal
extension. CaMV CP is involved in assembly (Chapdelaine
and Hohn, 1998), packaging of the viral RNA (Guerra-
Peraza et al., 2000), and delivery of the viral genome to the
nucleus (Karsies et al., 2002; Leclerc et al., 1999). These
various CP functions are probably regulated by several
events, including CP maturation by viral- and host-encoded
proteases, which cleave the N- and C-terminal extensions to
generate the three major forms of CP (p44, p39, and p37)
(Torruella et al., 1989); CP phosphorylation on S82,86,88 by0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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(D. Leclerc).host casein kinase II (Chapdelaine et al., 2002); interaction
with TAV (ORF VI product) (Himmelbach et al., 1996); the
protein degradation signal located in the N-terminal exten-
sion (Karsies et al., 2001); and retention of pre-CP in the
cytoplasm through an unknown mechanism involving the
N-terminal extension (Karsies et al., 2002). Although the
function of the N-terminal extension is still unknown, we
suspect it is essential for the virus life cycle. We hypothesize
that it plays a key role in the retention of CP in the
cytoplasm for viral assembly by acting as an anchoring
domain. To gain further insight into the role of the N-
terminal extension, we investigated its intracellular locali-
zation in CaMV-infected plants. Our results lead us to
propose a model of CaMV capsid assembly.Results
Purification of the N-terminal extension of CaMV pre-CP
To produce the N-terminal extension peptide of CaMV
pre-CP, we used the IMPACT TWIN system (New England
Biolabs, Beverly, MA). The N-terminal 76 amino acids of
Fig. 1. Purification of the N-terminal domain of CaMV capsid protein
precursor. (A) Schematic representation of the construct used to produce the
N-terminal domain of pre-CP. The first 76 N-terminal amino acids of the
precursor were inserted between the two self-cleaving inteins (Inteins 1 and
2) attached to the chitin-binding domain (CBD). The CBD allows the fusion
protein (CBD-Intein 1-Pre-CP N-terminal extension-Intein 2-CBD) to bind
to chitin beads. (B) Coomassie blue-stained 10% tricine SDS-PAGE gel
showing purification of N-terminal extension peptide. The position of
prestained molecular marker (kDa) are shown on the left. Expression of the
Intein-Pre-CP-N-terminal-extension fusion protein in E. coli ER2566 cells.
Lanes: 1, uninduced cell extract; 2, induced cell extract (the full-length
precursor is the most prominent band); 3–5, elution fractions following pH-
and temperature-dependent cleavage of Intein 1 (pH 7 at 25 jC) and thiol-
induced cleavage of Intein 2 (40 mM DTT). (C) Immunodetection of the
purified protein using anti-pIV1– 362 antibody; Lanes 3–5. (D) Western blot
showing that the N-terminal protein (residues 1–76) is indeed recognized
by the mouse antibody raised against it.
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of the expression vector pTWIN1 (Fig. 1A). This system
facilitated purification of a stable and soluble N-terminal
extension using self-cleavage and an affinity tag to chitin.Fig. 2. Western analysis of CaMV proteins from the purified virus and recombin
pIV1 – 265 expressed in E. coli and purified from inclusion bodies; 2, purified virus
purified using the IMPACT-TWIN system. Proteins were transferred onto nitrocellu
pIV1 – 362 (B) or a rat antibody against the N-terminal extension protein (C). The p
indicate the position of the N-terminal extension protein.Intein 1 is engineered to cleave at its C-terminus in a pH-
and temperature-dependent manner and Intein 2 undergoes
thiol-induced N-terminal cleavage. The overexpressed pro-
tein (pIV1–76) was affinity-purified using a resin covalently
bound to chitin, and the N-terminal extension was released
by a temperature/pH shift and addition of dithiothreitol. The
protein was analysed by SDS-10% PAGE (Fig. 1B) and
Western blot (Fig. 1C). A protein of the predicted mass (8.4
kDa) was obtained and recognized by an antibody generated
against pIV1–362 (previously described by Chapdelaine and
Hohn, 1998). A second passage of the eluted fractions over
the resin allowed removal of partially spliced or unspliced
products. Purified pIV1–76 was injected into a mouse and a
rat to produce specific IgGs. The polyclonal antibodies thus
produced specifically recognized the recombinant N-termi-
nal extension (Fig. 1D). However, due to nonspecific
binding to other plant proteins, antibody purification was
essential to avoid nonspecific labeling in subsequent elec-
tron microscopy studies. Antibodies were purified by affin-
ity to pIV1–265 on immunoblot (Harlow and Lane, 1988).
The purified recombinant N-terminal extension (Fig. 2A)
was specifically recognized by the purified antibodies (Fig.
2C) without reacting with the processed form (p44) of CP
found in the purified virus (Fig. 2C). As expected, the anti-
pIV1–362 antibody reacted with proteins pIV1–265 and
pIV1–76 (Fig. 2B). The anti-N-terminal antibody is specific
for the N-terminal extension, making it an ideal tool with
which to study the localization of the extension in planta.
Infection of plants
Brassica rapa plants were inoculated with 1 Ag of
linearized CaMV DNA (SalI digest of an infectious isolate
of CaMV cloned in plasmid pBR322). Local symptoms
appeared 15 days post inoculation (dpi). Symptoms were
systemic after 30 days and typical electron-dense inclusion
bodies containing virus particles were observed by 30 dpi at
the ultrastructural level (see Figs. 3B–E).ant capsid protein. (A) Coomassie blue-stained SDS-PAGE gel. Lanes: 1,
(only the p44 form was present); 3, N-terminal extension protein (pIV1– 76)
lose and blotted using an antibody directed against the capsid precursor anti
ositions of size markers (kDa) are indicated on the left of each blot. Arrows
Fig. 3. Transmission electron micrographs of healthy and CaMV-infected B. rapa leaf tissue, collected 30 days after infection. CW, cell wall; Ch, chloroplast;
IB, inclusion body; IS, intracellular space; N, nucleus; SB, small body and V, virus. Immunogold labeling was performed on thin sections with the purified
mouse polyclonal antibody (anti-N-terminal domain) as primary antibody followed by colloidal gold (10 nm)-conjugated goat anti-mouse IgG + IgM. (A)
Sections from healthy plant controls are free of labeling (40000). (B) Localization of the N-terminal domain of CaMV pre-CP. A small body (SB) structure
neighboring the larger electron-dense inclusion body (IB) is specifically labeled (arrow) (30000). (C) Enlargement of B showing the deposition of gold
particles over the small body, particularly over the virions (arrow) (80000). (D) Another infected cell, showing labeling of the small body (100000). (E)
Immunogold labeling with pVI antibody: the inclusion body matrix is labeled. Deposition of gold particles over the small body can also be seen (60000).
J. Champagne et al. / Virology 324 (2004) 257–262 259Intracellular localization of the N-terminal domain of
pre-CP in infected turnip leaf cells
Immunogold labeling was performed on thin sections of
infected leaves at seven different times postinfection. The
purified antiserum produced against the N-terminal exten-
sion was used to localize the N-terminal extension of pre-CP
in infected plant leaves. In sections from control leaves
(healthy plants) (Fig. 3A), no labeling was detected, indi-cating the absence of any endogenous substrate for the
antibody. At early times in the infection process (1, 3, 6,
10 15, and 20 dpi), inclusion bodies were not found within
the host cells and all sections examined were free of labeling
(data not shown). By 30 dpi, gold particles were found to
specifically accumulate over small dense structures, which
we have named ‘‘small bodies’’. A delay of 30 days is rather
a long period to trigger an infection. This is probably due to
the use of DNA instead of virions for inoculation, DNA
J. Champagne et al. / Virology 324 (2004) 257–262260being less infectious than CaMV particles. It is also possible
that some plant cells could not support CaMV replication
because they got damaged during bombardment. As illus-
trated in Figs. 3B–D, small bodies (arrows) neighbored
larger inclusion bodies containing viruses and were specif-
ically labeled. The N-terminal extension appeared to be
located at the virion surface. Specificity of labeling was
assessed by omission of the primary antibody. This resulted
in loss of deposition of gold particles over the small bodies
(data not shown). Likewise, no labeling was observed over
the host cell organelles, cell walls, and cytoplasm. The N-
terminal extension of pre-CP was associated only with viral
particles seen inside small bodies. Specificity of the labeling
with the antibody raised against the viral pVI protein (TAV)
was also assessed. The pattern was found to be similar to that
previously described (Giband et al., 1984), with pVI being
present in both the large and small inclusion body matrices
(Fig. 3E). We have observed specific labeling of small
inclusion bodies with the antibodies more than 30 times on
10 different sections made from 10 different blocks. These
results are very reproducible and the labeling was very
specific. The small inclusion bodies were always associated
with large inclusion bodies and always labeled with the N-
terminal antibodies. We did not find small inclusion bodies
under our conditions that was not labeled with the anti-
bodies. The small bodies contain between two and eight gold
particles with an average of five gold particles, whereas the
large inclusion was never labeled. We also observed large
inclusion bodies in some cells that were not labeled and
where small inclusion bodies were absent.Discussion
The assembly process of CaMV remains only partially
understood. The Gag protein of the animal retrovirus family,
a model for CaMV and the plant pararetrovirus group, is
known to anchor in the plasma membrane before assembly
and encapsidation (Ono et al., 2000). By analogy, it is
possible that CaMV also anchors its CP to a specific site
where the protein accumulates and where assembly and
encapsidation is triggered. Several lines of evidence suggest
that the cytoplasmic inclusion bodies are the site of viral
protein accumulation and virion assembly (Hohn and Fu¨t-
terer, 1991; Shepherd, 1976). Previous electron microscopy
studies have demonstrated the association of virus particles
with the inclusion bodies (Giband et al., 1984; Shepherd et
al., 1976). The interaction between the CP (pIV) and TAV,
the viral inclusion body protein (pVI) seems to play a role in
CaMVassembly (Himmelbach et al., 1996; Kobayashi et al.,
1998). However, the involvement of TAV in assembly is so
far only speculative. Our objective was to identify a cellular
compartment that could be important for accumulation of
the CaMV pre-CP.
As proposed by Karsies et al. (2002), pre-CP is produced
and remains in the cytoplasm during the CaMV replicationcycle. p44, a processed form of the capsid starting at aa 77,
harbors a nuclear localization signal (NLS), which is of key
importance for nuclear targeting of CP transiently expressed
in plant protoplasts (Karsies et al., 2002; Leclerc et al.,
1999). However, in such experiments, pre-CP remained in
the cytoplasm (Karsies et al., 2002). The N-terminal exten-
sion of the pre-CP appears to change the localization of the
protein from nuclear to cytoplasmic. In this report, we used
immunogold electron microscopy to reveal localization of
pre-CP in planta to small inclusion bodies (small bodies)
located in close proximity to the cell membrane. The small
bodies are specifically labeled with antibodies directed
towards the N-terminal extension of pre-CP, and are closely
associated with viral particles. This result suggests that
processing of pre-CP by the virus-encoded protease occurs
after assembly of virus particles. The large inclusion bodies
were free of labeling, which suggests that only mature virus
particles are found in the large inclusion bodies. We did not
find the free N-terminal peptide in our Western blot assay.
Because it is always associated with the small inclusion
bodies, we suggest that the N-terminal extension is mostly
present as part of the pre-capsid protein. Antibodies directed
to TAV (pVI) also labeled the small inclusion bodies,
suggesting that the interaction between TAV and the pre-
CP is important early in assembly. Events before the
formation of the small bodies are unclear because we could
not detect labeling in any other structure of the infected cell.
We propose that the N-terminal extension targets the pre-CP
to an assembly site, presumably the plasma membrane of the
infected cell and, upon accumulation of the protein in the
anchoring sites, triggers assembly of the virion. Assembly is
followed by aggregation of the particles into small inclusion
bodies with the help of TAV (ORF VI product). Small
inclusion bodies in close proximity to larger inclusion
bodies were also observed in an electron microscopy study
in Dahlia mosaic virus (DMV; also member of the Cauli-
moviridae family) infected leaves (Kitajima et al., 1969).
They suggested that the virus particles are assembled in the
inclusion bodies and that the Golgi might be associated with
viral infection. For both virus, internal membranes such as
cell membrane (CaMV) or Golgi (DMV) seem to be
important for the assembly process and the formation of
small inclusion bodies.
According to our observations, the following scheme of
events can be proposed for viral assembly (Fig. 4). As
infection progresses, the CaMV pre-CP protein accumulates
at specific sites, possibly the plasma membrane. The N-
terminal extension may operate as an anchoring domain for
the initiation of viral assembly. In a wide sense, we propose
homology of function with the viral matrix protein of HIV.
In HIV-1, myristoylation of the matrix domain of Gag
polyprotein is crucial to ensure its targeting to the plasma
membrane, where assembly and budding occur (Gelderblom
et al., 1989; Pal et al., 1990). Although the N-terminal
extension of pre-CP does not share sequence homology with
the HIV-1 matrix protein, we propose that it plays an
Fig. 4. Proposed model for CaMVassembly. As infection proceeds, the coat
protein precursor (amino acids 1–489) is synthesized and retained in the
cytoplasm by the N-terminal extension of the pre-CP (black box at the N-
terminus of the pre-CP) (Step 1). The coat protein precursor accumulates in
a cytoplasmic compartment, presumably the plasma membrane. The N-
terminal extension may act as an anchoring domain. As coat protein
concentration increases, RNA or reverse-transcribed DNA is available to
trigger viral assembly (Step 2). The small bodies containing the N-terminal
extension and viruses formed (Step 3) and the N-terminal extension is then
cleaved by the viral protease (Step 4). Finally, the small bodies fuse to form
a larger inclusion body (IB). Fusion process may be mediated by the viral
pVI protein.
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nism, the viral coat protein accumulates until a specific
concentration is reached and genomic RNA or reverse-
transcribed DNA is available to trigger viral assembly.
The immature virion then gathers in small bodies containing
the N-terminal domain of CaMV CP. The viral CP is finally
cleaved by the viral protease, removing the N-terminal
extension from the precursor. The pre-CP is also processed
at its C-terminal domain and it is still unknown if the
cleavage is regulated in the same manner as the N-terminal
extension. Following the final processing, the newly formed
mature virions in small bodies fuse and contribute to the
expansion of the large inclusion bodies. We propose that the
pVI–pIV interaction might be important for the regulation
of the progression from small to large inclusion bodies
because the N-terminal and C-terminal domains of pre-CP
were shown to interfere with this interaction (Himmelbach
et al., 1996). Our data suggest that pVI is present in the
small inclusion bodies. How the interaction between pVI
and pIV differs in the large and in the small inclusion
bodies, and how this interaction is regulated, remains
unclear. We are currently investigating this question.Materials and methods
Plant material and infection
B. rapa plants (var ‘‘Just Right’’) were grown in a
greenhouse at 20 F 2 jC with a 16 h photoperiod. Two-week-old turnip plants were infected with an infectious
CaMV clone (isolate Cabb-B-S; a kind gift from T. Hohn),
excised by digestion with SalI from cloned DNA in the
vector pBR322. After ligation, 1 Ag of viral DNA previ-
ously precipitated with 1.6-Am gold microcarrier was
injected into plant cells by particle bombardment [Helios
Gene Gun (Bio-Rad)] in accordance with the manufactur-
er’s instruction manual. The virus was purified as de-
scribed previously (Hull et al., 1976).
Production of antibodies against the N-terminal domain of
CaMV pre-CP
The N-terminal domain of CaMV pre-CP was amplified
by PCR using the clone (isolate Cabb-B-S) containing the
whole genome of CaMV in pBR322 as a template. Specific
PCR primers incorporated NcoI and XhoI restriction sites at
the N- and C-terminal ends, respectively. The fragment was
cloned in frame in the pTWIN-1 vector (New England
Biolabs) between the two self-cleaving inteins (Intein 1,
Ssp DnaB intein and Intein 2, Mxe Gyr A intein) with
chitin-binding domain, under the control of the T7 promot-
er. Expression and purification of the protein were essen-
tially as described by the manufacturer (NEB) for N- and C-
terminal intein fusions. Briefly, E. coli ER2566 cells con-
taining the plasmid were grown for 3 h in 2XYT medium
with 100 Ag ampicillin at 37 jC to an A600 = 0.5–0.7.
Proteins were induced with 1 mM IPTG overnight at room
temperature. The cells were pelleted, followed by resus-
pension in buffer B2 (20 mM Hepes, pH 7, 500 mM NaCl,
1 mM EDTA) and lysed using a French Press. The cell
lysate was centrifuged and the supernatant applied to a
chitin bead column equilibrated with 10 volumes of buffer
B2. Unbound proteins were washed off with the same
buffer, after which self-cleavage of Intein 1 in buffer B2
(pH 7 at 25 jC overnight) and Intein 2 in buffer B3 at 4 jC
(20 mM Hepes, pH 8.5, 200 mM NaCl, 1 mM EDTA, and
40 mM DTT) were induced. The protein was eluted in the
presence of 40 mM DTT in buffer B3. The recovered
protein was analyzed on 10% SDS-PAGE (Schagger and
von Jagow, 1987) and electroblotted onto nitrocellulose at
400 mA for 45 min. Blots were probed using rabbit anti-
pIV1–362 antibodies (raised against amino acids 1–362 of
the coat protein; Chapdelaine and Hohn, 1998) or mouse
(rat) polyclonal antibodies produced against the N-terminal
extension (see below). Binding of primary antibody was
detected with HRP-conjugated secondary antibodies (Amer-
sham Pharmacia) and chemiluminescent immunodetection
reagent as described by the manufacturer (ECL system,
Amersham).
A mouse and a rat were immunized intraperitoneally with
150 Al (30 Ag) of the N-terminal protein emulsified with an
equal volume of Freund’s adjuvant. Two additional injec-
tions at 2-week intervals were administrated with Freund’s
incomplete adjuvant and a third was administrated without
adjuvant. The presence of antibodies against the protein was
J. Champagne et al. / Virology 324 (2004) 257–262262determined by ELISA and Western blot. The antibody was
purified by immunoblot against the protein corresponding to
amino acids 1–265 of the viral coat protein cloned in the
vector pET3d, overexpressed in E. coli BL21, and purified
as previously described (Chapdelaine and Hohn, 1998).
pIV1–265 protein was isolated from bacterial inclusion
bodies that were solubilized in 8 M urea and renatured by
dialysis against TBS. The purified antibody was collected in
100 mm glycine, pH 2.5, and neutralized in 1/10 volume of
1 M Tris (pH 8.0).
Tissue processing for transmission electron microscopy
Leaf samples were collected at 1, 3, 6, 10, 15, 20, and
30 dpi. Noninfected plants were used as a control. After
fixation by immersion in 3% (w/v) paraformaldehyde in
0.1 M cacodylate buffer (pH 7.2) at room temperature for
3 h, samples were dehydrated in a graded ethanol series
and embedded in L. R. White resin (Hard Grade acrylic
resin, Canemco supplies). Ultrathin sections (90–100 nm)
were cut with a diamond knife (RMC-MT 7000) and
collected on Formvar-coated nickel grids. Sections were
processed for immunocytochemical labeling.
Immunocytochemical labeling
For indirect labeling, sections were blocked for 30 min
in one drop of 0.01 M sodium phosphate-buffered saline
(PBS) containing 1%(w/v) skim milk powder pH 7.2 at
room temperature. They were then transferred to a drop of
primary antibody (mouse anti-N-terminal domain of pre-
CP) in PBS-1% skim milk powder milk for 2 h. Grids
were washed with PBS (pH 7.2) plus 0.05% Tween 20
and incubated on a drop of colloidal gold (10 nm)-
conjugated goat anti-mouse IgG + IgM (British Biocell)
diluted 1:20 in PBS–1% skim milk powder (pH 7.2) for 1
h. Grids were finally washed with PBS–0.05% Tween 20,
rinsed with distilled water, and contrasted with 3% uranyl
acetate before examination with a JEOL 1200 EX electron
microscope (JEOL Co., Japan) at 80 kV. Specificity of
labeling was assessed with polyclonal antibody specific
for the viral pVI protein (1:500) and omission of the first
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